As per the latest report by IMARC Group, titled "Lignans Market Report by Source (Oilseeds, Cereals and Grains, Plant Resins), Application (Food and Beverages, Cosmetics and Toiletries, Pharmaceuticals, Animal Nutrition, and Others), and Region 2025-2033," the global lignans market size reached USD 463.2 Million in 2024. Lignans are a group of natural compounds found in plants that offer a range of health benefits. They are formed through lignification, which occurs when plants convert simple molecules into lignin, a complex polymer that provides structural support. Lignans are derived from the breakdown of lignin in the human body or through the consumption of lignan-rich foods, such as flaxseeds, sesame seeds, and whole grains. Once ingested, lignans are metabolized by intestinal bacteria into active compounds, such as enterolignans, which exert various biological effects. They are known for their antioxidant and phytoestrogenic properties, which enable them to scavenge harmful free radicals and mimic or modulate the action of estrogen in the body. These characteristics contribute to their potential health benefits, including reducing the risk of cardiovascular disease, cancer, and menopausal symptoms. There are several types of lignans available in the market, including secoisolariciresinol, matairesinol, pinoresinol, lariciresinol, and enterolignans, such as enterodiol and enterolactone.
Global Lignans Market Trends:
The surging consumer awareness regarding the health benefits of lignans is one of the key factors creating a positive outlook for the market. Additionally, the growing demand for natural and plant-based ingredients in the food and beverage (F&B) industry and the rising popularity of functional foods and dietary supplements are propelling the market growth. In confluence with this, the surging product application in the pharmaceutical and cosmetics and personal care industries are favoring the market growth. The burgeoning research and development (R&D) activities focused on exploring the therapeutic potential of lignans and the growing prevalence of chronic diseases, such as cardiovascular disorders, diabetes, and cancer, are acting as other factors influencing the market growth. Apart from this, the escalating interest in preventive healthcare measures, inflating disposable incomes, and changing consumer preferences toward natural and organic products are fueling the market growth. Other factors, such as the easy availability of lignan-rich plant sources, the expansion of distribution channels, including e-commerce platforms, and favorable government regulations and policies promoting natural ingredients, are facilitating the market growth. Looking forward, the market value is projected to reach USD 794.6 Million by 2033, expanding at a CAGR of 5.69% during 2025-2033.
Market Summary:
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Million USD |
Segment Coverage | Source, Application, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | BioGin Biochemicals Co. Ltd., FarmaSino Pharmaceuticals (Jiangsu) Co. Ltd., Hebei Xinqidian Biotechnology Co. Ltd., Kingherbs Limited, Naturalin Bio-Resources Co. Ltd., Plamed Green Science Group, Prairie Tide Diversified Inc., Zebrago Industrial Co. Limited and SPI Pharma |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800